Rare
lephants
Screener
Toggle theme
Cell Source, Inc.
CLCS
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Returns on Capital
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Returns on Capital
Chart
Table
ROE
ROI
ROA
Fiscal Year
ROE
ROI
ROA
FY2023
34.1%
34.1%
-2,726.4%
FY2024
24.3%
24.3%
-1,575.1%
Download CSV
